nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Administration site reaction—Mesalazine—Crohn's disease	0.0597	0.0597	CcSEcCtD
Gadoversetamide—Diarrhoea haemorrhagic—Mesalazine—Crohn's disease	0.0296	0.0296	CcSEcCtD
Gadoversetamide—Meningitis—Azathioprine—Crohn's disease	0.0212	0.0212	CcSEcCtD
Gadoversetamide—Rectal tenesmus—Mesalazine—Crohn's disease	0.0201	0.0201	CcSEcCtD
Gadoversetamide—Proctalgia—Mesalazine—Crohn's disease	0.016	0.016	CcSEcCtD
Gadoversetamide—Rectal disorder—Mesalazine—Crohn's disease	0.0153	0.0153	CcSEcCtD
Gadoversetamide—Anorectal disorder—Mesalazine—Crohn's disease	0.0142	0.0142	CcSEcCtD
Gadoversetamide—Anorectal discomfort—Mesalazine—Crohn's disease	0.0137	0.0137	CcSEcCtD
Gadoversetamide—Urine abnormality—Mesalazine—Crohn's disease	0.0135	0.0135	CcSEcCtD
Gadoversetamide—Local reaction—Mesalazine—Crohn's disease	0.0135	0.0135	CcSEcCtD
Gadoversetamide—Urine analysis abnormal—Mesalazine—Crohn's disease	0.0127	0.0127	CcSEcCtD
Gadoversetamide—Parosmia—Mesalazine—Crohn's disease	0.0115	0.0115	CcSEcCtD
Gadoversetamide—Burning sensation—Mesalazine—Crohn's disease	0.0108	0.0108	CcSEcCtD
Gadoversetamide—Metrorrhagia—Mesalazine—Crohn's disease	0.0105	0.0105	CcSEcCtD
Gadoversetamide—Tongue disorder—Mesalazine—Crohn's disease	0.0103	0.0103	CcSEcCtD
Gadoversetamide—Meningitis—Prednisone—Crohn's disease	0.0102	0.0102	CcSEcCtD
Gadoversetamide—Amblyopia—Mesalazine—Crohn's disease	0.00969	0.00969	CcSEcCtD
Gadoversetamide—Feeling hot—Mesalazine—Crohn's disease	0.00953	0.00953	CcSEcCtD
Gadoversetamide—Rhinorrhoea—Mesalazine—Crohn's disease	0.00924	0.00924	CcSEcCtD
Gadoversetamide—Breast pain—Mesalazine—Crohn's disease	0.00858	0.00858	CcSEcCtD
Gadoversetamide—Vasodilation—Mesalazine—Crohn's disease	0.00852	0.00852	CcSEcCtD
Gadoversetamide—Vasodilation procedure—Mesalazine—Crohn's disease	0.00852	0.00852	CcSEcCtD
Gadoversetamide—Musculoskeletal stiffness—Mesalazine—Crohn's disease	0.00834	0.00834	CcSEcCtD
Gadoversetamide—Endophthalmitis—Prednisone—Crohn's disease	0.00831	0.00831	CcSEcCtD
Gadoversetamide—Dysmenorrhoea—Mesalazine—Crohn's disease	0.00823	0.00823	CcSEcCtD
Gadoversetamide—Hypocalcaemia—Mesalazine—Crohn's disease	0.00817	0.00817	CcSEcCtD
Gadoversetamide—Neck pain—Mesalazine—Crohn's disease	0.00757	0.00757	CcSEcCtD
Gadoversetamide—Eructation—Mesalazine—Crohn's disease	0.00735	0.00735	CcSEcCtD
Gadoversetamide—Melaena—Mesalazine—Crohn's disease	0.00731	0.00731	CcSEcCtD
Gadoversetamide—Cramps of lower extremities—Mesalazine—Crohn's disease	0.00687	0.00687	CcSEcCtD
Gadoversetamide—Ecchymosis—Mesalazine—Crohn's disease	0.00676	0.00676	CcSEcCtD
Gadoversetamide—Hypertonia—Mesalazine—Crohn's disease	0.00656	0.00656	CcSEcCtD
Gadoversetamide—Ear pain—Mesalazine—Crohn's disease	0.00637	0.00637	CcSEcCtD
Gadoversetamide—Immune system disorder—Mercaptopurine—Crohn's disease	0.00625	0.00625	CcSEcCtD
Gadoversetamide—Disorientation—Mesalazine—Crohn's disease	0.00607	0.00607	CcSEcCtD
Gadoversetamide—Malnutrition—Mercaptopurine—Crohn's disease	0.00603	0.00603	CcSEcCtD
Gadoversetamide—Eye pain—Mesalazine—Crohn's disease	0.00602	0.00602	CcSEcCtD
Gadoversetamide—Increased appetite—Mesalazine—Crohn's disease	0.00578	0.00578	CcSEcCtD
Gadoversetamide—Thirst—Mesalazine—Crohn's disease	0.00571	0.00571	CcSEcCtD
Gadoversetamide—Face oedema—Mesalazine—Crohn's disease	0.00524	0.00524	CcSEcCtD
Gadoversetamide—Arthralgia—Mercaptopurine—Crohn's disease	0.00513	0.00513	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.0051	0.0051	CcSEcCtD
Gadoversetamide—Blood creatinine increased—Mesalazine—Crohn's disease	0.00509	0.00509	CcSEcCtD
Gadoversetamide—Dry skin—Mesalazine—Crohn's disease	0.00498	0.00498	CcSEcCtD
Gadoversetamide—Oedema—Mercaptopurine—Crohn's disease	0.00492	0.00492	CcSEcCtD
Gadoversetamide—Nasopharyngitis—Mesalazine—Crohn's disease	0.00486	0.00486	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00482	0.00482	CcSEcCtD
Gadoversetamide—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00479	0.00479	CcSEcCtD
Gadoversetamide—Skin disorder—Mercaptopurine—Crohn's disease	0.00478	0.00478	CcSEcCtD
Gadoversetamide—Influenza—Mesalazine—Crohn's disease	0.00469	0.00469	CcSEcCtD
Gadoversetamide—Asthma—Mesalazine—Crohn's disease	0.00469	0.00469	CcSEcCtD
Gadoversetamide—Dysphagia—Mesalazine—Crohn's disease	0.00469	0.00469	CcSEcCtD
Gadoversetamide—Anorexia—Mercaptopurine—Crohn's disease	0.00469	0.00469	CcSEcCtD
Gadoversetamide—Pneumonia—Azathioprine—Crohn's disease	0.00462	0.00462	CcSEcCtD
Gadoversetamide—Bronchospasm—Mesalazine—Crohn's disease	0.00462	0.00462	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00448	0.00448	CcSEcCtD
Gadoversetamide—Dysuria—Mesalazine—Crohn's disease	0.00439	0.00439	CcSEcCtD
Gadoversetamide—Decreased appetite—Mercaptopurine—Crohn's disease	0.00428	0.00428	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00425	0.00425	CcSEcCtD
Gadoversetamide—Pneumonia—Mesalazine—Crohn's disease	0.00421	0.00421	CcSEcCtD
Gadoversetamide—Haemoglobin—Azathioprine—Crohn's disease	0.00415	0.00415	CcSEcCtD
Gadoversetamide—Haemorrhage—Azathioprine—Crohn's disease	0.00412	0.00412	CcSEcCtD
Gadoversetamide—Conjunctivitis—Mesalazine—Crohn's disease	0.00407	0.00407	CcSEcCtD
Gadoversetamide—Urinary tract infection—Mesalazine—Crohn's disease	0.00407	0.00407	CcSEcCtD
Gadoversetamide—Haematuria—Mesalazine—Crohn's disease	0.00399	0.00399	CcSEcCtD
Gadoversetamide—Epistaxis—Mesalazine—Crohn's disease	0.00395	0.00395	CcSEcCtD
Gadoversetamide—Sinusitis—Mesalazine—Crohn's disease	0.00393	0.00393	CcSEcCtD
Gadoversetamide—Erythema multiforme—Azathioprine—Crohn's disease	0.0039	0.0039	CcSEcCtD
Gadoversetamide—Body temperature increased—Mercaptopurine—Crohn's disease	0.00389	0.00389	CcSEcCtD
Gadoversetamide—Haemoglobin—Mesalazine—Crohn's disease	0.00378	0.00378	CcSEcCtD
Gadoversetamide—Rhinitis—Mesalazine—Crohn's disease	0.00377	0.00377	CcSEcCtD
Gadoversetamide—Haemorrhage—Mesalazine—Crohn's disease	0.00376	0.00376	CcSEcCtD
Gadoversetamide—Pharyngitis—Mesalazine—Crohn's disease	0.00373	0.00373	CcSEcCtD
Gadoversetamide—Immune system disorder—Azathioprine—Crohn's disease	0.00373	0.00373	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Azathioprine—Crohn's disease	0.00372	0.00372	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Mesalazine—Crohn's disease	0.00371	0.00371	CcSEcCtD
Gadoversetamide—Oedema peripheral—Mesalazine—Crohn's disease	0.0037	0.0037	CcSEcCtD
Gadoversetamide—Chills—Azathioprine—Crohn's disease	0.0037	0.0037	CcSEcCtD
Gadoversetamide—Arrhythmia—Azathioprine—Crohn's disease	0.00368	0.00368	CcSEcCtD
Gadoversetamide—Urethral disorder—Mesalazine—Crohn's disease	0.00368	0.00368	CcSEcCtD
Gadoversetamide—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00362	0.00362	CcSEcCtD
Gadoversetamide—Ecchymosis—Prednisone—Crohn's disease	0.00358	0.00358	CcSEcCtD
Gadoversetamide—Erythema multiforme—Mesalazine—Crohn's disease	0.00355	0.00355	CcSEcCtD
Gadoversetamide—Eye disorder—Mesalazine—Crohn's disease	0.00351	0.00351	CcSEcCtD
Gadoversetamide—Tinnitus—Mesalazine—Crohn's disease	0.0035	0.0035	CcSEcCtD
Gadoversetamide—Cardiac disorder—Mesalazine—Crohn's disease	0.00349	0.00349	CcSEcCtD
Gadoversetamide—Angiopathy—Mesalazine—Crohn's disease	0.00341	0.00341	CcSEcCtD
Gadoversetamide—Immune system disorder—Mesalazine—Crohn's disease	0.00339	0.00339	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Mesalazine—Crohn's disease	0.00339	0.00339	CcSEcCtD
Gadoversetamide—Chills—Mesalazine—Crohn's disease	0.00337	0.00337	CcSEcCtD
Gadoversetamide—Diarrhoea—Mercaptopurine—Crohn's disease	0.00337	0.00337	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Azathioprine—Crohn's disease	0.00333	0.00333	CcSEcCtD
Gadoversetamide—Thrombophlebitis—Prednisone—Crohn's disease	0.00332	0.00332	CcSEcCtD
Gadoversetamide—Mental disorder—Mesalazine—Crohn's disease	0.00329	0.00329	CcSEcCtD
Gadoversetamide—Erythema—Mesalazine—Crohn's disease	0.00327	0.00327	CcSEcCtD
Gadoversetamide—Malaise—Azathioprine—Crohn's disease	0.00324	0.00324	CcSEcCtD
Gadoversetamide—Flatulence—Mesalazine—Crohn's disease	0.00322	0.00322	CcSEcCtD
Gadoversetamide—Tension—Mesalazine—Crohn's disease	0.00321	0.00321	CcSEcCtD
Gadoversetamide—Dysgeusia—Mesalazine—Crohn's disease	0.0032	0.0032	CcSEcCtD
Gadoversetamide—Nervousness—Mesalazine—Crohn's disease	0.00318	0.00318	CcSEcCtD
Gadoversetamide—Back pain—Mesalazine—Crohn's disease	0.00316	0.00316	CcSEcCtD
Gadoversetamide—Muscle spasms—Mesalazine—Crohn's disease	0.00314	0.00314	CcSEcCtD
Gadoversetamide—Vomiting—Mercaptopurine—Crohn's disease	0.00313	0.00313	CcSEcCtD
Gadoversetamide—Injury—Prednisone—Crohn's disease	0.00313	0.00313	CcSEcCtD
Gadoversetamide—Rash—Mercaptopurine—Crohn's disease	0.0031	0.0031	CcSEcCtD
Gadoversetamide—Dermatitis—Mercaptopurine—Crohn's disease	0.0031	0.0031	CcSEcCtD
Gadoversetamide—Vision blurred—Mesalazine—Crohn's disease	0.00308	0.00308	CcSEcCtD
Gadoversetamide—Tremor—Mesalazine—Crohn's disease	0.00306	0.00306	CcSEcCtD
Gadoversetamide—Increased appetite—Prednisone—Crohn's disease	0.00306	0.00306	CcSEcCtD
Gadoversetamide—Amnesia—Prednisone—Crohn's disease	0.00306	0.00306	CcSEcCtD
Gadoversetamide—Myalgia—Azathioprine—Crohn's disease	0.00306	0.00306	CcSEcCtD
Gadoversetamide—Arthralgia—Azathioprine—Crohn's disease	0.00306	0.00306	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00304	0.00304	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Mesalazine—Crohn's disease	0.00303	0.00303	CcSEcCtD
Gadoversetamide—Discomfort—Azathioprine—Crohn's disease	0.00302	0.00302	CcSEcCtD
Gadoversetamide—Malaise—Mesalazine—Crohn's disease	0.00295	0.00295	CcSEcCtD
Gadoversetamide—Vertigo—Mesalazine—Crohn's disease	0.00294	0.00294	CcSEcCtD
Gadoversetamide—Syncope—Mesalazine—Crohn's disease	0.00293	0.00293	CcSEcCtD
Gadoversetamide—Nausea—Mercaptopurine—Crohn's disease	0.00292	0.00292	CcSEcCtD
Gadoversetamide—Palpitations—Mesalazine—Crohn's disease	0.00289	0.00289	CcSEcCtD
Gadoversetamide—Loss of consciousness—Mesalazine—Crohn's disease	0.00287	0.00287	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Azathioprine—Crohn's disease	0.00287	0.00287	CcSEcCtD
Gadoversetamide—Cough—Mesalazine—Crohn's disease	0.00285	0.00285	CcSEcCtD
Gadoversetamide—Skin disorder—Azathioprine—Crohn's disease	0.00285	0.00285	CcSEcCtD
Gadoversetamide—Hypertension—Mesalazine—Crohn's disease	0.00282	0.00282	CcSEcCtD
Gadoversetamide—Arthralgia—Mesalazine—Crohn's disease	0.00278	0.00278	CcSEcCtD
Gadoversetamide—Chest pain—Mesalazine—Crohn's disease	0.00278	0.00278	CcSEcCtD
Gadoversetamide—Myalgia—Mesalazine—Crohn's disease	0.00278	0.00278	CcSEcCtD
Gadoversetamide—Anxiety—Mesalazine—Crohn's disease	0.00277	0.00277	CcSEcCtD
Gadoversetamide—Face oedema—Prednisone—Crohn's disease	0.00277	0.00277	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00277	0.00277	CcSEcCtD
Gadoversetamide—Discomfort—Mesalazine—Crohn's disease	0.00275	0.00275	CcSEcCtD
Gadoversetamide—Hypotension—Azathioprine—Crohn's disease	0.00274	0.00274	CcSEcCtD
Gadoversetamide—Dry mouth—Mesalazine—Crohn's disease	0.00272	0.00272	CcSEcCtD
Gadoversetamide—Confusional state—Mesalazine—Crohn's disease	0.00269	0.00269	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00267	0.00267	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Mesalazine—Crohn's disease	0.00267	0.00267	CcSEcCtD
Gadoversetamide—Oedema—Mesalazine—Crohn's disease	0.00267	0.00267	CcSEcCtD
Gadoversetamide—Dry skin—Prednisone—Crohn's disease	0.00263	0.00263	CcSEcCtD
Gadoversetamide—Shock—Mesalazine—Crohn's disease	0.00263	0.00263	CcSEcCtD
Gadoversetamide—Nervous system disorder—Mesalazine—Crohn's disease	0.00262	0.00262	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Mesalazine—Crohn's disease	0.00261	0.00261	CcSEcCtD
Gadoversetamide—Tachycardia—Mesalazine—Crohn's disease	0.00261	0.00261	CcSEcCtD
Gadoversetamide—Skin disorder—Mesalazine—Crohn's disease	0.00259	0.00259	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Mesalazine—Crohn's disease	0.00258	0.00258	CcSEcCtD
Gadoversetamide—Anorexia—Mesalazine—Crohn's disease	0.00254	0.00254	CcSEcCtD
Gadoversetamide—Muscular weakness—Prednisone—Crohn's disease	0.00253	0.00253	CcSEcCtD
Gadoversetamide—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00253	0.00253	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00253	0.00253	CcSEcCtD
Gadoversetamide—Hypotension—Mesalazine—Crohn's disease	0.00249	0.00249	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00243	0.00243	CcSEcCtD
Gadoversetamide—Sweating increased—Prednisone—Crohn's disease	0.00242	0.00242	CcSEcCtD
Gadoversetamide—Feeling abnormal—Azathioprine—Crohn's disease	0.00241	0.00241	CcSEcCtD
Gadoversetamide—Insomnia—Mesalazine—Crohn's disease	0.00241	0.00241	CcSEcCtD
Gadoversetamide—Paraesthesia—Mesalazine—Crohn's disease	0.0024	0.0024	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Azathioprine—Crohn's disease	0.0024	0.0024	CcSEcCtD
Gadoversetamide—Dyspnoea—Mesalazine—Crohn's disease	0.00238	0.00238	CcSEcCtD
Gadoversetamide—Somnolence—Mesalazine—Crohn's disease	0.00237	0.00237	CcSEcCtD
Gadoversetamide—Dyspepsia—Mesalazine—Crohn's disease	0.00235	0.00235	CcSEcCtD
Gadoversetamide—Decreased appetite—Mesalazine—Crohn's disease	0.00232	0.00232	CcSEcCtD
Gadoversetamide—Abdominal pain—Azathioprine—Crohn's disease	0.00232	0.00232	CcSEcCtD
Gadoversetamide—Body temperature increased—Azathioprine—Crohn's disease	0.00232	0.00232	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.0023	0.0023	CcSEcCtD
Gadoversetamide—Fatigue—Mesalazine—Crohn's disease	0.0023	0.0023	CcSEcCtD
Gadoversetamide—Constipation—Mesalazine—Crohn's disease	0.00228	0.00228	CcSEcCtD
Gadoversetamide—Pain—Mesalazine—Crohn's disease	0.00228	0.00228	CcSEcCtD
Gadoversetamide—Hyperglycaemia—Prednisone—Crohn's disease	0.00224	0.00224	CcSEcCtD
Gadoversetamide—Feeling abnormal—Mesalazine—Crohn's disease	0.0022	0.0022	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00218	0.00218	CcSEcCtD
Gadoversetamide—Hypersensitivity—Azathioprine—Crohn's disease	0.00216	0.00216	CcSEcCtD
Gadoversetamide—Urticaria—Mesalazine—Crohn's disease	0.00212	0.00212	CcSEcCtD
Gadoversetamide—Abdominal pain—Mesalazine—Crohn's disease	0.00211	0.00211	CcSEcCtD
Gadoversetamide—Body temperature increased—Mesalazine—Crohn's disease	0.00211	0.00211	CcSEcCtD
Gadoversetamide—Diarrhoea—Azathioprine—Crohn's disease	0.00201	0.00201	CcSEcCtD
Gadoversetamide—Haemoglobin—Prednisone—Crohn's disease	0.002	0.002	CcSEcCtD
Gadoversetamide—Haemorrhage—Prednisone—Crohn's disease	0.00199	0.00199	CcSEcCtD
Gadoversetamide—Hallucination—Prednisone—Crohn's disease	0.00198	0.00198	CcSEcCtD
Gadoversetamide—Hypersensitivity—Mesalazine—Crohn's disease	0.00197	0.00197	CcSEcCtD
Gadoversetamide—Dizziness—Azathioprine—Crohn's disease	0.00194	0.00194	CcSEcCtD
Gadoversetamide—Asthenia—Mesalazine—Crohn's disease	0.00192	0.00192	CcSEcCtD
Gadoversetamide—Pruritus—Mesalazine—Crohn's disease	0.00189	0.00189	CcSEcCtD
Gadoversetamide—Vomiting—Azathioprine—Crohn's disease	0.00186	0.00186	CcSEcCtD
Gadoversetamide—Eye disorder—Prednisone—Crohn's disease	0.00186	0.00186	CcSEcCtD
Gadoversetamide—Rash—Azathioprine—Crohn's disease	0.00185	0.00185	CcSEcCtD
Gadoversetamide—Dermatitis—Azathioprine—Crohn's disease	0.00185	0.00185	CcSEcCtD
Gadoversetamide—Flushing—Prednisone—Crohn's disease	0.00184	0.00184	CcSEcCtD
Gadoversetamide—Headache—Azathioprine—Crohn's disease	0.00184	0.00184	CcSEcCtD
Gadoversetamide—Diarrhoea—Mesalazine—Crohn's disease	0.00183	0.00183	CcSEcCtD
Gadoversetamide—Angiopathy—Prednisone—Crohn's disease	0.0018	0.0018	CcSEcCtD
Gadoversetamide—Immune system disorder—Prednisone—Crohn's disease	0.0018	0.0018	CcSEcCtD
Gadoversetamide—Arrhythmia—Prednisone—Crohn's disease	0.00178	0.00178	CcSEcCtD
Gadoversetamide—Dizziness—Mesalazine—Crohn's disease	0.00177	0.00177	CcSEcCtD
Gadoversetamide—Mental disorder—Prednisone—Crohn's disease	0.00174	0.00174	CcSEcCtD
Gadoversetamide—Nausea—Azathioprine—Crohn's disease	0.00174	0.00174	CcSEcCtD
Gadoversetamide—Malnutrition—Prednisone—Crohn's disease	0.00173	0.00173	CcSEcCtD
Gadoversetamide—Erythema—Prednisone—Crohn's disease	0.00173	0.00173	CcSEcCtD
Gadoversetamide—Vomiting—Mesalazine—Crohn's disease	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Rash—Mesalazine—Crohn's disease	0.00168	0.00168	CcSEcCtD
Gadoversetamide—Dermatitis—Mesalazine—Crohn's disease	0.00168	0.00168	CcSEcCtD
Gadoversetamide—Headache—Mesalazine—Crohn's disease	0.00167	0.00167	CcSEcCtD
Gadoversetamide—Vision blurred—Prednisone—Crohn's disease	0.00163	0.00163	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Prednisone—Crohn's disease	0.00161	0.00161	CcSEcCtD
Gadoversetamide—Agitation—Prednisone—Crohn's disease	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Nausea—Mesalazine—Crohn's disease	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Malaise—Prednisone—Crohn's disease	0.00156	0.00156	CcSEcCtD
Gadoversetamide—Vertigo—Prednisone—Crohn's disease	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Syncope—Prednisone—Crohn's disease	0.00155	0.00155	CcSEcCtD
Gadoversetamide—Loss of consciousness—Prednisone—Crohn's disease	0.00152	0.00152	CcSEcCtD
Gadoversetamide—Convulsion—Prednisone—Crohn's disease	0.0015	0.0015	CcSEcCtD
Gadoversetamide—Hypertension—Prednisone—Crohn's disease	0.00149	0.00149	CcSEcCtD
Gadoversetamide—Myalgia—Prednisone—Crohn's disease	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Arthralgia—Prednisone—Crohn's disease	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Anxiety—Prednisone—Crohn's disease	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00146	0.00146	CcSEcCtD
Gadoversetamide—Discomfort—Prednisone—Crohn's disease	0.00146	0.00146	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Prednisone—Crohn's disease	0.00141	0.00141	CcSEcCtD
Gadoversetamide—Oedema—Prednisone—Crohn's disease	0.00141	0.00141	CcSEcCtD
Gadoversetamide—Shock—Prednisone—Crohn's disease	0.00139	0.00139	CcSEcCtD
Gadoversetamide—Nervous system disorder—Prednisone—Crohn's disease	0.00139	0.00139	CcSEcCtD
Gadoversetamide—Tachycardia—Prednisone—Crohn's disease	0.00138	0.00138	CcSEcCtD
Gadoversetamide—Skin disorder—Prednisone—Crohn's disease	0.00137	0.00137	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Prednisone—Crohn's disease	0.00137	0.00137	CcSEcCtD
Gadoversetamide—Anorexia—Prednisone—Crohn's disease	0.00135	0.00135	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00129	0.00129	CcSEcCtD
Gadoversetamide—Insomnia—Prednisone—Crohn's disease	0.00128	0.00128	CcSEcCtD
Gadoversetamide—Paraesthesia—Prednisone—Crohn's disease	0.00127	0.00127	CcSEcCtD
Gadoversetamide—Dyspepsia—Prednisone—Crohn's disease	0.00124	0.00124	CcSEcCtD
Gadoversetamide—Decreased appetite—Prednisone—Crohn's disease	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Fatigue—Prednisone—Crohn's disease	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Constipation—Prednisone—Crohn's disease	0.00121	0.00121	CcSEcCtD
Gadoversetamide—Feeling abnormal—Prednisone—Crohn's disease	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Prednisone—Crohn's disease	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Urticaria—Prednisone—Crohn's disease	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Abdominal pain—Prednisone—Crohn's disease	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Body temperature increased—Prednisone—Crohn's disease	0.00112	0.00112	CcSEcCtD
Gadoversetamide—Hypersensitivity—Prednisone—Crohn's disease	0.00104	0.00104	CcSEcCtD
Gadoversetamide—Asthenia—Prednisone—Crohn's disease	0.00101	0.00101	CcSEcCtD
Gadoversetamide—Pruritus—Prednisone—Crohn's disease	0.000999	0.000999	CcSEcCtD
Gadoversetamide—Diarrhoea—Prednisone—Crohn's disease	0.000966	0.000966	CcSEcCtD
Gadoversetamide—Dizziness—Prednisone—Crohn's disease	0.000934	0.000934	CcSEcCtD
Gadoversetamide—Vomiting—Prednisone—Crohn's disease	0.000898	0.000898	CcSEcCtD
Gadoversetamide—Rash—Prednisone—Crohn's disease	0.000891	0.000891	CcSEcCtD
Gadoversetamide—Dermatitis—Prednisone—Crohn's disease	0.00089	0.00089	CcSEcCtD
Gadoversetamide—Headache—Prednisone—Crohn's disease	0.000885	0.000885	CcSEcCtD
Gadoversetamide—Nausea—Prednisone—Crohn's disease	0.000839	0.000839	CcSEcCtD
